As shown in Figure 6A,B, there is no difference in the TRIM10 expression level in AML cells that were treated with chidamide versus those that were not, indicating that epigenetic repression of TRIM10 expression might involve an alternative mechanism. Here, TRIM10 is linked to acute myeloid leukemia.